Elevai Labs, Inc. Common Stock (ELAB)

US · Healthcare · Biotechnology

$4.72-1.05%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$1.3M

Net profit

$-2.9M

EPS

$-0.61

Net margin

-225.1%

Market cap

$3.9M

Forward P/E

0.0

P/B

0.23

Book value

$27.20

EPS (TTM)

$-1,870.17

52-week high

$2,671.20

52-week low

$4.40

50-day MA

$8.12

200-day MA

$148.09

Beta

-0.30

Insiders

5.61%

Institutions

3.29%

Fund	Stake
Jane Street Group LLC	0.39%
Morgan Stanley - Brokerage Accounts	0.19%
Schonfeld Strategic Advisors LLC	0.18%
UBS Group AG	0.02%
IFP Advisors, LLC	0.01%
Tower Research Capital LLC	0.00%
Danske Bank A/S.	0.00%
Bank of America Corp	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Elevai Labs, Inc. Common Stock — free to start.

Data updated 2026-09-18.